卒中后第一年临床上肢测量与传感器手臂使用指标的结构效度与反应性
结果显示临床测量与患侧手臂使用指标呈中高度正相关,非患侧单侧使用时长与临床测量负相关;反应性在D10-D28最高,临床测量与GRPC相关性强于手臂使用指标,并估计了最小重要变化的切点值。
要点
- 临床上肢测量与患侧手臂使用指标在D28后呈中高度正相关(rs 0.57-0.88)。
- 非患侧单侧手臂使用时长与临床测量呈负相关(rs -0.48至-0.77)。
- D10-D28反应性最高,GRPC与临床测量相关性(rs 0.60-0.73)强于手臂使用指标(rs 0.28-0.43)。
核心结论
- 临床上肢测量与排除步行及非功能运动后的传感器手臂使用指标在卒中后第一年具有可接受的结构效度,且临床测量的反应性优于手臂使用指标。
- 估计的最小重要变化切点值可作为卒中康复临床基准。
研究设计与样本
- 在卒中后3±2、10±2、28±4、90±7及365±14天进行临床评估与连续3天佩戴5个运动传感器(躯干、双腕、双踝)。
主要发现
- D3和D10时临床测量与手臂使用指标相关性变异较大(rs 0.44-0.90),后续时间点患侧手臂使用指标与临床测量呈中高度正相关(rs 0.57-0.88)。
- 非患侧单侧手臂使用时长与临床测量呈负相关(rs -0.48至-0.77)。
- GRPC与临床测量的反应性在D10-D28最高(rs 0.60-0.73),手臂使用指标较弱(rs 0.28-0.43)。
- 为临床测量估计8个MIC值、为手臂使用指标估计9个MIC值,准确度中等至良好(66-87%)。
关键数值与推荐
- 临床测量包括Fugl-Meyer评估、Action Research Arm Test、Box & Block Test及14项Motor Activity Log。
- MIC切点值通过ROC曲线分析估计,准确度66-87%。
临床怎么用
- 卒中后第一年可结合临床上肢测量与传感器手臂使用指标综合评估运动恢复。
- 关注非患侧单侧手臂使用时长增加,可能提示患侧使用减少。
- MIC值可作为临床康复中判断最小重要变化的参考基准。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Construct validity and responsiveness of upper limb outcome measures are essential to interpret motor recovery poststroke. Evaluating the associations between clinical upper limb measures and sensor-based arm use (AU) fosters a coherent understanding of motor recovery. Defining sensor-based AU metrics for intentional upper limb movements could be crucial in mitigating bias from walking-related activities. Here, we investigate the measurement properties of a comprehensive set of clinical measures and sensor-based AU metrics when gait and non-functional upper limb movements are excluded. METHODS: In this prospective, longitudinal cohort study, individuals with motor impairment were measured at days 3 ± 2 (D3), 10 ± 2 (D10), 28 ± 4 (D28), 90 ± 7 (D90), and 365 ± 14 (D365) after their first stroke. Using clinical measures, upper limb motor function (Fugl-Meyer Assessment), capacity (Action Research Arm Test, Box & Block Test), and perceived performance (14-item Motor Activity Log) were assessed. Additionally, individuals wore five movement sensors (trunk, wrists, and ankles) for three days. Thirteen AU metrics were computed based on functional movements during non-walking periods. Construct validity across clinical measures and AU metrics was determined by Spearman's rank correlations for each time point. Criterion responsiveness was examined by correlating patient-reported Global Rating of Perceived Change (GRPC) scores and observed change in upper limb measures and AU metrics. Optimal cut-off values for minimal important change (MIC) were estimated by ROC curve analysis. RESULTS: Ninety-three individuals participated. At D3 and D10, correlations between clinical measures and AU metrics showed variability (range rs: 0.44-0.90). All following time points showed moderate-to-high positive correlations between clinical measures and affected AU metrics (range rs: 0.57-0.88). Unilateral nonaffected AU duration was negatively correlated with clinical measures (range rs: -0.48 to -0.77). Responsiveness across outcomes was highest between D10-D28 within moderate to strong relations between GRPC and clinical measures (rs: range 0.60-0.73), whereas relations were weaker for AU metrics (range rs: 0.28-0.43) Eight MIC values were estimated for clinical measures and nine for AU metrics, showing moderate to good accuracy (66-87%). CONCLUSIONS: We present reference data on the construct validity and responsiveness of clinical upper limb measures and specified sensor-based AU metrics within the first year after stroke. The MIC values can be used as a benchmark for clinical stroke rehabilitation. TRIAL REGISTRATION: This trial was registered on clinicaltrials.gov; registration number NCT03522519.
引用
- Pohl J, Verheyden G, Held JPO, et al. Construct validity and responsiveness of clinical upper limb measures and sensor-based arm use within the first year after stroke: a longitudinal cohort study. J Neuroeng Rehabil. 2025. PMID: 39881332. doi:10.1186/s12984-024-01512-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。